TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with Journalist BRIAN CHRISTIAN & UC Berkeley Professor TOM GRIFFITHS, the Director of the Computational Cognitive Science Lab about their book, “Algorithms to Live By: The Computer Science of Human Decisions”. Then on Biotech Nation, it’s all about Youth Rally, an annual camp for kids and teens with conditions of the bowel and bladder. We’ll hear from its chair, PAUL HASTINGS, who is also the President and CEO of OncoMed Pharmaceuticals, as well as Youth Rally’s, APRIL GIMLEN, and EMILY MALLAR.

On this week’s Tech Nation, Moira speaks with … SC MOATTI about her background with Facebook, Trulia and Nokia, and her book, “Mobilized …. An insider’s guide to the business and future of connected technology”. Then on BioTech Nation, how much do we know about the clinical trials behind drugs approved by the FDA? JENNIFER MILLER, the Founder and President of Bioethics, International and a professor at NYU Medical School, talks about the Good Pharma Scorecard.

On this week’s Tech Nation, Moira speaks with … SC MOATTI about her background with Facebook, Trulia and Nokia, and her book, “Mobilized …. An insider’s guide to the business and future of connected technology”. Then on BioTech Nation, how much do we know about the clinical trials behind drugs approved by the FDA? JENNIFER MILLER, the Founder and President of Bioethics, International and a professor at NYU Medical School, talks about the Good Pharma Scorecard.

On this week’s Tech Nation, Moira speaks with … SC MOATTI about her background with Facebook, Trulia and Nokia, and her book, “Mobilized …. An insider’s guide to the business and future of connected technology”. Then on BioTech Nation, how much do we know about the clinical trials behind drugs approved by the FDA? JENNIFER MILLER, the Founder and President of Bioethics, International and a professor at NYU Medical School, talks about the Good Pharma Scorecard.

On this week’s Tech Nation, Moira speaks with … SC MOATTI about her background with Facebook, Trulia and Nokia, and her book, “Mobilized …. An insider’s guide to the business and future of connected technology”. Then on BioTech Nation, how much do we know about the clinical trials behind drugs approved by the FDA? JENNIFER MILLER, the Founder and President of Bioethics, International and a professor at NYU Medical School, talks about the Good Pharma Scorecard.

On this week’s Tech Nation, Moira speaks with neuroscientist Dr. Alex Pang about “Rest … Why You Get More Done When You Work Less.” Then on BioTech Nation, the focus is Alzheimer’s Disease. Dr. Gunn speaks with Kevin Cox, CEO of Imanova about the ability to actually examine the state of the brain on a more routine basis, improving diagnosis and predicting the success or failure of drugs. Then, it’s Dr. Charles Stacey, the President and CEO of Accera. The basis for their Alzheimer’s treatment centers on glucose uptake in the brain.

On this week’s Tech Nation, Moira speaks with neuroscientist Dr. Alex Pang about “Rest … Why You Get More Done When You Work Less.” Then on BioTech Nation, the focus is Alzheimer’s Disease. Dr. Gunn speaks with Kevin Cox, CEO of Imanova about the ability to actually examine the state of the brain on a more routine basis, improving diagnosis and predicting the success or failure of drugs. Then, it’s Dr. Charles Stacey, the President and CEO of Accera. The basis for their Alzheimer’s treatment centers on glucose uptake in the brain.

On this week’s Tech Nation, Moira speaks with cognitive scientist Dr. Alexandra Horowitz, the Director of the Dog Cognition Lab at Barnard. She’s the author of “Being a Dog: Following the Dog into a World of Smell.” Then on BioTech Nation, Dr. Ignacio Pino, the CEO of the next generation proteomics company, CDI, located in Mayaguez, Puerto Rico.

On this week’s Tech Nation, Moira speaks with cognitive scientist Dr. Alexandra Horowitz, the Director of the Dog Cognition Lab at Barnard. She’s the author of “Being a Dog: Following the Dog into a World of Smell.” Then on BioTech Nation, Dr. Ignacio Pino, the CEO of the next generation proteomics company, CDI, located in Mayaguez, Puerto Rico.

On this week’s Tech Nation, Moira speaks with DR. SUSAN DAVID, a psychologist on the faculty of Harvard Medical School. She tells us about “Emotional Agility” - what is it, how we can use, and what science can tell us about how it actually works. Then on BioTech Nation, Daniel Zurr, CEO of Quark Pharmaceuticals. Their approach uses a part of the immune system called siRNA, and they are working on treatments for kidney damage following open heart surgery, damage to kidneys during the transplantation process, and sudden vision loss.

On this week’s Tech Nation, Moira speaks with DR. SUSAN DAVID, a psychologist on the faculty of Harvard Medical School. She tells us about “Emotional Agility” - what is it, how we can use, and what science can tell us about how it actually works. Then on BioTech Nation, Daniel Zurr, CEO of Quark Pharmaceuticals. Their approach uses a part of the immune system called siRNA, and they are working on treatments for kidney damage following open heart surgery, damage to kidneys during the transplantation process, and sudden vision loss.

On this week’s Tech Nation, Moira speaks with Brian Sager, the Co-Founder, President and CEO of Omnity, a search engine – not based on keywords, but search in the context of entire documents. Google isn’t going away – but your need to find information is growing. Then on BioTech Nation, the promise and challenges of cancer immunotherapy. Dr. Gunn speaks with Dr. Sean McCarthy, the CEO of CytomX Therapeutics.

On this week’s Tech Nation, Moira speaks with Brian Sager, the Co-Founder, President and CEO of Omnity, a search engine – not based on keywords, but search in the context of entire documents. Google isn’t going away – but your need to find information is growing. Then on BioTech Nation, the promise and challenges of cancer immunotherapy. Dr. Gunn speaks with Dr. Sean McCarthy, the CEO of CytomX Therapeutics.

On this week’s Tech Nation, Moira speaks with MIT professor Sherry Turkle about the psychological effect of the 2016 presidential campaign. Her latest book is “Reclaiming Conversation … The Power of Talk in a Digital Age”. Then on BioTech Nation, in the pediatric area, diagnosing some behavioral problems and mental disorders by testing the immune system. Dr. Craig Shimasaki, the CEO of Moleculera Labs, explains their test and the science behind it.

On this week’s Tech Nation, Moira speaks with MIT professor Sherry Turkle about the psychological effect of the 2016 presidential campaign. Her latest book is “Reclaiming Conversation … The Power of Talk in a Digital Age”. Then on BioTech Nation, in the pediatric area, diagnosing some behavioral problems and mental disorders by testing the immune system. Dr. Craig Shimasaki, the CEO of Moleculera Labs, explains their test and the science behind it.